Improving cancer treatment for dogs using immunotherapy
Advancing the Coordinating Center for the Canine Cancer Immunotherapy Network
This study is all about making it easier to test new immunotherapy treatments for dogs with cancer, so we can help them feel better and possibly learn things that could help people with cancer too!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10923962 on NIH RePORTER |
What this research studies
This research focuses on enhancing the coordination of clinical trials that test immunotherapy treatments for dogs suffering from cancer. The University of Pennsylvania's coordinating center will work with various sites to ensure that dogs with spontaneous cancer are effectively studied, which may also provide insights for human cancer treatments. The project involves comprehensive management of trial activities, regulatory compliance, and data collection to support the research. By collaborating with experts and utilizing advanced technologies, the center aims to streamline the process of conducting these important trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are dogs diagnosed with spontaneous cancer that may be eligible for immunotherapy trials.
Not a fit: Dogs without a cancer diagnosis or those not suitable for immunotherapy will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments for dogs, which may also inform and improve therapies for humans.
How similar studies have performed: Previous research in canine immunotherapy has shown promising results, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mason, Nicola J — University of Pennsylvania
- Study coordinator: Mason, Nicola J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.